Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (143K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (108)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Holz, B.
Right arrow Articles by Weinhold, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holz, B.
Right arrow Articles by Weinhold, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research Pages 1076-1083


2-Aminopurine as a fluorescent probe for DNA base flipping by methyltransferases
Introduction
Materials And Methods
   Oligodeoxynucleotide synthesis, purification and evaluation
   DNA methyltransferases
   Gel mobility shift assays
   Steady-state fluorescence measurements
   Fluorescence data processing
Results
   Duplex oligodeoxynucleotides used
   Binding of M.HhaI and M.TaqI to duplex oligodeoxynucleotides
   Fluorescence studies with M.HhaI
   Fluorescence studies with M.TaqI
Discussion
Acknowledgements
References


2-Aminopurine as a fluorescent probe for DNA base flipping by methyltransferases

2-Aminopurine as a fluorescent probe for DNA base flipping by methyltransferases Birgit Holz, Saulius Klimasauskas1, Saulius Serva1 and Elmar Weinhold*

Max-Planck-Institut für Molekulare Physiologie, Abteilung Physikalische Biochemie, Rheinlanddamm 201, D-44139 Dortmund, Germany and 1Institute of Biotechnology, Graiciuno 8, LT-2028 Vilnius, Lithuania

Received September 19, 1997; Revised and Accepted December 22, 1997

ABSTRACT

DNA base flipping, which was first observed for the C5-cytosine DNA methyltransferase M.HhaI, results in a complete removal of the stacking interactions between the target base and its neighbouring bases. We have investigated whether duplex oligodeoxynucleotides containing the fluorescent base analogue 2-aminopurine can be used to sense DNA base flipping. Using M.HhaI as a paradigm for a base flipping enzyme, we find that the fluorescence intensity of duplex oligodeoxynucleotides containing 2-aminopurine at the target site is dramatically enhanced (54-fold) in the presence of M.HhaI. Duplex oligodeoxynucleotides containing 2-aminopurine adjacent to the target cytosine show little fluorescence increase upon addition of M.HhaI. These results clearly demonstrate that duplex oligodeoxynucleotides containing 2-aminopurine at the target site can serve as fluorescence probes for base flipping. Another enzyme hypothesized to use a base flipping mechanism is the N6-adenine DNA methyltransferase M.TaqI. Addition of M.TaqI to duplex oligodeoxynucleotides bearing 2-aminopurine at the target position, also results in a strongly enhanced fluorescence (13-fold), whereas addition to duplex oligodeoxynucleotides containing 2-aminopurine at the 3'- or 5'-neighbouring position leads only to small fluorescence increases. These results give the first experimental evidence that the adenine-specific DNA methyltransferase M.TaqI also flips its target base.

INTRODUCTION

Specific binding of proteins to DNA often leads to drastic conformational changes in the DNA structure. Proteins can bend, kink, unwind and melt the DNA or can flip out a whole base (nucleotide) from the double helix. Base flipping was initially observed by X-ray crystallography for the C5-cytosine DNA methyltransferase from Haemophilus haemolyticus (M.HhaI) (1). Subsequently, a second C5-cytosine DNA methyltransferase, from Haemophilus aegypticus (M.HaeIII) (2), the thymidine dimer excision repair enzyme endonuclease V (3) and the uracil DNA glycosylase (4) were seen to use a base flipping mechanism. In all four protein-DNA complexes a base is completely rotated out of the DNA double helix. The C5-cytosine DNA methyltransferases and the uracil DNA glycosylase have their target bases flipped out of the DNA helix into a cleft within each enzyme, where catalysis takes place. In contrast, with endonuclease V one of the partner adenines of the thymidine dimer is flipped into a hydrophobic pocket of the enzyme permitting the catalytic residues to reach the target thymidine dimer. In all these cases base flipping allows the catalytic machinery to gain access to the target site within the bulky DNA substrate.

It has been postulated that base flipping occurred early in evolution and that it might be found in many DNA modifying enzymes (5). Possible candidates are other C5-cytosine DNA methyltransferases, N6-adenine and N4-cytosine DNA methyltransferases as well as DNA glycosylases and DNA repair enzymes. This hypothesis is supported by a number of X-ray structures of enzymes, which have been crystallized without their DNA substrates. The catalytic sites of O6-methylguanine DNA methyltransferase (6), [beta]-glucosyl transferase (7), exonuclease III (8), photolyase (9), endonuclease III (10), DNA 3-methyl adenine glycosylase II (11,12) and N4-cytosine DNA methyltransferase M.PvuII (13) were all found in the interior of the proteins. In each instance, base flipping appears to be necessary to bring the active site amino acid residues in close proximity to the target deoxynucleotide.

A similar example is the N6-adenine DNA methyltransferase from Thermus aquaticus (M.TaqI), which catalyses the methyl group transfer from S-adenosyl-l-methionine (AdoMet) to the exocyclic amino group of adenine within the double-stranded (ds) 5'-TCGA-3' DNA sequence (14). The structure of M.TaqI in complex with its cofactor consists of two domains which form a cleft wide enough to accommodate dsDNA (15). However, modelling of B-DNA into the M.TaqI structure showed that the distance between the target adenine and the activated methyl group of the cofactor is 15 Å, which is too large for direct methyl group transfer (16). By rotating the adenine out of the DNA helix towards the cofactor, the distance between the methyl group donor and acceptor can be significantly reduced, and hence a base flipping mechanism was proposed for M.TaqI. A structural comparison of M.TaqI with the base flipping C5-cytosine DNA methyltransferase M.HhaI showed that the catalytic domains of both enzymes have a very similar fold (17), although primary structural similarities between the two enzymes are limited to a few sequence motifs (18,19). In a superimposition of the catalytic domains of M.TaqI and M.HhaI both the cofactors and the catalytic motifs (N/D P P Y/F/W-motif for N6-adenine DNA methyltransferases and PC-motif for C5-cytosine DNA methyltransferases) overlay very well (17). Because of the similar architecture of their catalytic domains a shared base flipping mechanism seems likely.

In general, X-ray crystallography of protein-DNA complexes provides the absolute proof of DNA base flipping. However, cocrystallization of proteins with their DNA substrates is often cumbersome, and in some cases cocrystals might never be obtained. Therefore, other methods suitable to detect DNA base flipping would be of great value. Recently, tighter binding of the two C5-cytosine DNA methyltransferases M.HhaI and M.HpaII to duplex oligodeoxynucleotides containing mismatched bases at their target sites (20,21) and of the N6-adenine DNA methyltransferase M.EcoRV to duplexes containing unnatural bases with reduced hydrogen bonding capabilities at the target site (22) was reported. An alternative approach to detect base flipping might use the fluorescent base analogue 2-aminopurine. This base is a very sensitive probe to detect conformational changes in DNA structure (23), and it can be incorporated into oligodeoxynucleotides by solid phase DNA synthesis (24-28). The 2-aminopurine fluorescence is highly quenched in polynucleotides (29), due to stacking interactions with neighbouring bases (30,31) and would be expected to increase dramatically if the 2-aminopurine base is flipped out of the DNA helix. Furthermore, the 2-aminopurine fluorescence excitation and emission maxima are well separated from those of tryptophan and tyrosine residues in proteins, increasing its usefulness for studying protein-DNA interactions. Duplex oligodeoxynucleotides containing 2-aminopurine have been used to study the Klenow fragment of DNA polymerase I (32,33), T4 DNA polymerase (34-36), T7 RNA polymerase (37-39), Escherichia coli RNA polymerase (40) and helicases (41,42). Recently, duplex oligodeoxynucleotides containing 2-aminopurine have been used to study the N6-adenine DNA methyltransferase M.EcoRI, and a DNA base flipping mechanism was suggested for this enzyme (43).

Using the C5-cytosine DNA methyltransferase M.HhaI as a paradigm for a base flipping enzyme, we demonstrate that 2-aminopurine incorporated in DNA serves as an excellent spectroscopic probe for DNA base flipping. M.HhaI recognizes the specific tetranucleotide DNA sequence 5'-GCGC-3' (44) and catalyses the methyl group transfer from AdoMet to the 5-position of the first cytosine (45). Titration with M.HhaI of a duplex oligodeoxynucleotide, in which the first cytosine is replaced with 2-aminopurine, yields a large increase in the 2-aminopurine fluorescence intensity. In addition, the N6-adenine DNA methyltransferase M.TaqI, which was suggested to use a base flipping mechanism, also shows a strongly enhanced 2-aminopurine fluorescence after addition to a duplex oligodeoxynucleotide, in which the target adenine is replaced by 2-aminopurine. Thus, duplex oligodeoxynucleotides containing 2-aminopurine can serve as spectroscopic probes for DNA base flipping in protein-DNA complexes. In addition, these duplex oligodeoxynucleotides should be very useful to study the dynamics of DNA base flipping.

MATERIALS AND METHODS

UV absorption spectra were measured in H2O using a Varian Cary 3E spectrometer. HPLC was performed using a Beckmann System Gold equipped with a programmable solvent module 125, a diode array detector module 168, an analog interface module 406 and a Shimadzu spectrofluorometric detector RF-551. Fluorescence data were collected with a SLM-Aminco AB2 spectrofluorometer. The excitation and emission bandwidths were adjusted to 2 and 8 nm, respectively. Displayed emission spectra were corrected for lamp intensity fluctuations. Fluorescence titrations were performed with an excitation wavelength of 320 nm and an emission wavelength of 381 nm to lower the influence of the natural DNA base absorption and the protein tryptophan fluorescence. Emission spectra were recorded with an excitation wavelength of 320 nm. Due to the optical arrangement of the SLM AB2 all 2-aminopurine emission spectra show an extra shoulder at around 380 nm.

Oligodeoxynucleotide synthesis, purification and evaluation

Oligodeoxynucleotides were synthesized on an Applied Biosystems 392 DNA/RNA synthesizer, using standard [beta]-cyanoethyl phosphoramidite chemistry or were purchased from MWG Biotech. 2-Aminopurine, C5-methylcytosine and N6-methyladenine phosphoramidites were purchased from Glen Research. Phosphoramidites for the normal bases and the synthesizer chemicals were obtained from Applied Biosystems and MWG Biotech. Phosphoramidites were dissolved manually in dry acetonitrile at 0.1 M concentration. Sequences of synthesized oligodeoxynucleotides are given in Table 1.

Evaluation of the coupling yield using the dimethoxytrityl cation assay gave an average of 98.5% per step. Deblocking was achieved by heating in aqueous ammonia (33%, Baker) at 55°C for 8 h. Syntheses were performed `trityl on', and oligodeoxynucleotides containing the dimethoxytrityl group were purified by reversed phase HPLC (Hypersil ODS, 5 µm, 120 Å, 250 × 8 mm column, Bischoff) with a linear acetonitrile gradient (13-31% in 20 min, 2.5 ml/min) in triethylammonium acetate buffer (0.1 M, pH 7.0). After detritylation with acetic acid (80%) and ethanol precipitation oligodeoxynucleotides were desalted by gel filtration (NAP column, Pharmacia). Concentrations of oligodeoxynucleotides were determined by UV absorbance at 260 nm using the sum of the extinction coefficients of the individual bases.

Base composition of oligodeoxynucleotides was analysed by enzymatic digestion with snake venom phosphodiesterase and alkaline phosphatase followed by analytical reversed phase HPLC (26,46). Normalized peak areas of UV absorption at 254 nm correlated well with the expected base composition of the individual oligodeoxynucleotides. Oligodeoxynucleotides were 5'-labelled by treatment with T4 polynucleotide kinase (New England Biolabs) and [[gamma]-32P]ATP (0.4 MBq/µl, Hartmann Analytik) and analysed by denaturing PAGE. Radioactivity was quantified using a Phosphoimager (Molecular Imager System GS 525, Bio-Rad). All oligodeoxynucleotides showed a purity >95%.

DNA methyltransferases

HhaI was essentially isolated as described earlier (47); exhaustive dialysis prior to chromatography yielded AdoMet-free enzyme. The enzyme was purified to homogeneity by passing it through a pre-column of Q-Sepharose followed by column chromatography on S-Sepharose.

M.TaqI was expressed in ER 2267 Escherichia coli cells (New England Biolabs) harbouring pAGL15-M13, which carries the gene for M.TaqI under the inducible tac-promotor. pAGL15-M13 was kindly provided by Drs Jack Benner and Cheryl Baxa, New England Biolabs. Cells were grown at 37°C to an optical density of 0.6 at 600 nm and induced with IPTG (0.1 mM final concentration). After induction (4 h) cells were harvested by centrifugation (30 min at 3500 r.p.m.) and lysed by sonication in buffer A (Mes/HEPES/sodium acetate buffer mix, 6.7 mM each, pH 7.5, 1 mM EDTA, 10 mM [beta]-mercaptoethanol and 10% glycerol), containing sodium chloride (200 mM) and phenylmethylsulfonyl fluoride (25 mg/l). After centrifugation (1 h at 35 000 g) the supernatant was loaded onto a cation exchange column (Poros HS/M, 26 × 95 mm, Perseptive Biosystems) and M.TaqI was eluted with a linear gradient of sodium chloride (0.2-1.0 M) in buffer A. Fractions containing M.TaqI were pooled, 3-fold diluted with buffer A and loaded onto a heparin column (heparin Sepharose CL 6B, 26 × 95 mm, Pharmacia). M.TaqI was eluted with a linear gradient of sodium chloride (0.2-1.0 M) in buffer A. Fractions containing M.TaqI were pooled, and the protein solution was concentrated by ultrafiltration (Centriprep 10, Amicon). The concentrated protein solution (10 ml) was loaded onto a gel filtration column (Superdex 75, 26 × 600 mm, Pharmacia) and eluted with a Tris-HCl buffer (20 mM, pH 7.4) containing potassium chloride (600 mM), EDTA (0.2 mM), DTE (2 mM) and glycerol (10%). Fractions containing M.TaqI were pooled, 2-fold diluted with glycerol and stored at -20°C. M.TaqI was at least 95% pure as judged by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (48) and staining with Coomassie Blue. However, it was found that some fraction of the protein still contained the cofactor AdoMet. AdoMet bound to M.TaqI was removed as previously described (49).

Concentrations of M.HhaI and M.TaqI were estimated by the method of Bradford (50) (Coomassie Protein Assay Reagent, Pierce) using bovine serum albumin as standard. Concentrations were calculated using molecular weights of 37 100 g/mol for M.HhaI and 47 900 g/mol for M.TaqI.

Gel mobility shift assays

DNA binding studies with M.HhaI were performed by incubating M.HhaI (50 nM) with 5'-32P-labelled duplexes oligodeoxynucleotides (5 nM) in buffer B (10 mM Tris-HCl, pH 7.4, 50 mM sodium chloride, 0.5 mM EDTA and 2 mM [beta]-mercaptoethanol) supplied with glycerol (5%) and, where applicable, S-adenosyl-l-homocysteine (100 µM) for 30 min at 8°C. Aliquots (5 µl) were loaded onto a non-denaturing polyacrylamide gel (13%, acrylamide:bisacrylamide = 19:1) and electrophoresis was carried out in Tris-borate (45 mM, pH 8.3) and EDTA (1 mM) at 8°C for 2 h. Dried gels were autoradiographed to an X-ray film and the films were scanned with a ScanMaker E6 densitometer (Microtek). DNA binding of M.TaqI was analysed by incubation of M.TaqI (30 nM) with 5'-32P-labelled duplexes oligodeoxynucleotides (1 nM) in buffer C (10 mM Tris-acetate, pH 7.9, 50 mM potassium acetate, 10 mM magnesium acetate, 1 mM DTT and 0.01% Triton X-100) supplied with BSA (0.1 mg/ml) and glycerol (10%) at 0°C for 10 min. Aliquots (10 µl) were loaded onto a non-denaturing polyacrylamide gel (10%, acrylamide:bisacrylamide = 19:1) and electrophoresis was carried out in a buffer (pH 8.5) containing Tris-HCl (25 mM), glycine (192 mM) and EDTA (1 mM) at 0°C for 2 h. Radioactivity in the gel was visualized by autoradiography using a Bio-Rad Phosphoimager.

Steady-state fluorescence measurements

Fluorescence measurements were performed in 5 × 5 mm cuvettes at 25°C. Titrations of duplex oligodeoxynucleotides (20 and 250 nM) with M.HhaI were performed in buffer B and with M.TaqI in buffer C (see gel mobility shift assays). S-adenosyl-l-homocysteine (50 µM) was added to buffer B for titrations of 2CGC and GC2G with M.HhaI. Duplex oligodeoxynucleotides were made by mixing strands containing 2-aminopurine or non-fluorescent control strands with a 1.1-fold molecular excess of methylated complementary strands in the appropriate buffer and heating at 95°C for 2 min followed by cooling to room temperature over a period of 4 h. Enzymatic digestion of the duplex oligodeoxynucleotide G2GC was done by addition of DNase I (0.1 µg, Boehringer Mannheim) and snake venom phosphodiesterase (2 µg, Boehringer Mannheim) to a solution (400 µl) containing G2GC (250 nM) and buffer B supplemented with magnesium chloride (5 mM).

Table 1. Sequences of duplex oligodeoxynucleotides and their abbreviations used in this publicationa

aThe bases targeted by M.HhaI and M.TaqI are printed in bold and the following symbols are used for modified nucleosides: 2, 2-aminopurine-1-[beta]-d-2'-deoxynucleoside; CMe, 5-methyl-2'-deoxycytidine and AMe, 6-methyl-2'-deoxyadenosine.

Fluorescence data processing

All fluorescence emission spectra and fluorescence intensities from titrations were corrected for protein tryptophan fluorescence by subtraction of control spectra and control titrations, where the 2-aminopurine fluorophor was replaced by adenine in the duplex oligodeoxynucleotides. In addition, fluorescence data were corrected for variable background emission of the solutions. This was necessary, because the 2-aminopurine fluorescence is highly quenched in duplex oligodeoxynucleotides and its fluorescence intensity at low duplex concentration used in this study (20 and 250 nM) is small compared with the background. Therefore, the fluorescence intensities of the various duplex oligodeoxynucleotides were measured at higher concentrations (typically between 0.5 and 4 µM). Fluorescence intensities of all duplex oligodeoxynucleotides containing 2-aminopurine showed a linear dependence on their concentrations. Fluorescence intensities at 20 and 250 nM concentration free of background were calculated from the obtained slopes. Titration data (fluorescence intensities as a function of total enzyme concentrations) were fitted to the real solution of the quadratic binding equation for one binding site (51) using the data analysis program GraFit (52).

RESULTS

Duplex oligodeoxynucleotides used

For fluorescence measurements with M.HhaI, which catalyses the methylation of the first cytosine within the ds 5'-GCGC-3' DNA sequence, we used three hemimethylated duplex oligodeoxynucleotides, which are derived from the recognition sequence (for abbreviations of duplex oligodeoxynucleotides see Table 1). In G2GC the target cytosine, in 2CGC its 5'-neighbour and in GC2G its 3'-neighbour, is replaced with the fluorescent base 2-aminopurine. Since the recognition sequence of M.HhaI is palindromic, M.HhaI can, in principle, bind in two orientations. In order to direct binding of M.HhaI in the orientation, in which 2-aminopurine (G2GC) or cytosine (2CGC and GC2C) is targeted, the complementary strand in these duplexes contained 5-methylcytosine at the other target position. Such a preference for single binding orientation was observed in cocrystals of M.HhaI with hemimethylated DNA (53).

Analogous hemimethylated duplex oligodeoxynucleotides were used for the fluorescence measurements with M.TaqI, which catalyses the methylation of the adenine within the ds 5'-TCGA-3' DNA sequence. In the duplex oligodeoxynucleotides TCG2 and TC2A the target adenine and its 5'-neighbour are replaced by 2-aminopurine, whereas in TCGA2 2-aminopurine occupies the 3'-neighbour position outside the recognition sequence. In order to direct binding in the desired orientation the complementary strands in these duplex oligodeoxynucleotides contained N6-methyladenine at the other target position.

The various duplex oligodeoxynucleotides containing 2-amino-purine showed quite different fluorescence intensities (Table 2). In general, the fluorescence intensities of duplex oligodeoxynucleotides, in which the 2-aminopurine base can form a Watson-Crick-like base pair with thymine, are lower than those having 2-aminopurine in a mismatch position. Apart from base pairing, the 2-aminopurine fluorescence in these duplex oligodeoxynucleotides is also quite sensitive to the sequence context.


Figure 1. Gel mobility shift analysis of the interactions between M·HhaI (50 nM) and duplex oligodeoxynucleotides (5 nM). Lanes 1-4 in the absence and lanes 5-8 in the presence of 100 µM S-adenosyl-l-homocysteine (AdoHcy).

Table 2. Fluorescence intensities of duplex oligodeoxynucleotides containing 2-aminopurine before and after titration with M.HhaI or M.TaqIa
  Duplex
containing
2-aminopurine
Fluorescence
before
titration (a.u.)
Fluorescence
after
titration (a.u.)
Relative
fluorescence
increase
1 G2GC 4.76 ± 0.04 255.3 ± 3.1 53.6 ± 2.1
2 2CGC 5.91 ± 0.05 8.7 ± 0.8 1.5 ± 0.2
3 GC2C 9.90 ± 0.40 18.0 ± 1.5 1.8 ± 0.2
4 TCG2 1.77 ± 0.06 23.0 ± 0.8 13.0 ± 0.9
5 TC2A 5.81 ± 0.27 9.9 ± 0.2 1.7 ± 0.1
6 TCGA2 4.45 ± 0.07 9.0 ± 0.1 2.0 ± 0.1
aFor the fluorescence titrations with M.HhaI (rows 1-3) and M.TaqI (rows 4-6) duplex oligodeoxynucleotides containing 2-aminopurine-1-[beta]-d-2'-deoxynucleoside (2) were used at 250 nM concentration and the excitation and emission wavelengths were set to 320 and 381 nm, respectively. Fluorescence intensities are given in arbitrary units (a.u.) and errors as standard deviations.

Binding of M.HhaI and M.TaqI to duplex oligodeoxynucleotides

Binding of M.HhaI and M.TaqI to the various duplex oligodeoxynucleotides was analysed in gel mobility shift assays. The results obtained with M.HhaI are shown in Figure 1. Duplex oligodeoxynucleotides were incubated with M.HhaI and the free duplex oligodeoxynucleotides (lower bands) separated from the M.HhaI-bound duplexes (upper bands) by non-denaturing gel electrophoresis. Under these conditions M.HhaI completely bound to G2GC, partly to the specific duplex oligodeoxynucleotide GCGC and no binding was observed with 2CGC and GC2G (lanes 1-4). However, addition of S-adenosyl-l-homocysteine (AdoHcy) to the incubation mixture resulted in nearly complete binding of all duplex oligodeoxynucleotides (lanes 5-8). Binding of M.TaqI to specific duplex oligodeoxynucleotide TCGA and the various duplex oligodeoxynucleotides containing 2-aminopurine is demonstrated in Figure 2. The electrophoretic mobilities of the duplex oligodeoxynucleotides alone are shown in lanes 1, 3, 5 and 7. Addition of M.TaqI (30 nM) prior to electrophoresis resulted in nearly complete formation of complexes for all four duplex oligodeoxynucleotides even in the absence of AdoHcy (upper bands in lanes 2, 4, 6 and 8). Gel mobility shift experiments with different M.TaqI concentrations showed that with increasing M.TaqI concentrations the ratio between complexes with lower mobility and complexes with higher mobility changed in favour of the complexes with lower mobility (data not shown). These results suggest that the complexes with lower mobility may represent complexes in which multiple M.TaqI molecules are bound to the duplex oligodeoxynucleotides.


Figure 2. Gel mobility shift analysis of the interactions between M.TaqI and duplex oligodeoxynucleotides (1 nM). Lanes 1, 3, 5 and 7 in the absence of M.TaqI and lanes 2, 4, 6 and 8 in the presence of M.TaqI (30 nM).


Figure 3. Fluorescence emission spectra of G2GC: curve (a) 250 nM duplex oligodeoxynucleotide alone, curve (b) 10 µM duplex oligodeoxynucleotide alone, curve (c) 250 nM duplex oligodeoxynucleotide in the presence of saturating concentration of M.HhaI (2 µM) and curve (d) 250 nM duplex oligodeoxynucleotide after digestion with DNase I and phosphodiesterase.

Fluorescence studies with M.HhaI

Fluorescence spectra of G2GC, which places the 2-aminopurine fluorophor at the target site of M.HhaI, are shown in Figure 3. The 2-aminopurine fluorescence intensity of G2GC is very low at the concentration used in this study (curve a), but can be readily observed at higher levels (curve b). This is due to a very strong quenching of the fluorophor, which mainly results from stacking interactions with the neighbouring bases. The degree of fluorescence quenching in G2GC was determined by digestion with DNase I and phosphodiesterase. Enzymatic degradation of the duplex and release of the free 2-aminopurine-2'-deoxynucleotide (curve d) leads to a 100-fold increase of the fluorescence intensity at 381 nm. Upon addition of saturating amounts of M.HhaI to G2GC the 2-aminopurine fluorescence intensity at 381 nm increases 54-fold (Fig. 3, curve c and Table 2). Furthermore, the shape of the fluorescence emission spectrum in the presence of M.HhaI is changed compared with the duplex spectrum, but resembles that of the free 2-aminopurine-2'-deoxynucleotide. This can be seen in Figure 3 by comparing the fluorescence emission spectrum of G2GC at 10 µM concentration (curve b) with those of G2GC at 250 nM concentration in the presence of M.HhaI and after enzymatic digestion (curves c and d, respectively). The emission spectrum of G2GC in the presence of M.HhaI shows a maximum at 359 nm, which is very close to the maximum of the free 2-aminopurine-2'-deoxynucleotide at 360 nm. Figure 4A shows a titration curve of G2GC with M.HhaI. The fluorescence signal reaches saturation within the concentration range used. However, because of the high concentration of G2GC (250 nM) used no accurate dissociation constant, Kd, could be determined in this experiment. Titrations with 20 nM G2GC (Fig. 4B) yielded Kd of 3.9 ± 1.1 and 2.9 ± 0.9 nM in the absence and presence of AdoHcy, respectively, which agrees well with the values determined in gel mobility shift assays (S. Serva and S. Klimasauskas, unpublished data).AB


Figure 4. (A) Fluorescence titrations of G2GC (-), 2CGC ([diamonds]) and GC2C ([circle]) at 250 nM concentration each with M.HhaI. Titrations of 2CGC and GC2C were done in the presence of S-adenosyl-l-homocysteine (50 µM). (B) Fluorescence titrations of G2GC at 20 nM concentration in the absence (-) and presence of 50 µM S-adenosyl-l-homocysteine ([circle]) with M.HhaI. Data fitting yielded dissociation constants Kd of 3.9 ± 1.1 and 2.9 ± 0.9 nM in the absence and presence of S-adenosyl-l-homocysteine, respectively.

The duplex oligodeoxynucleotides bearing 2-aminopurine at the 5'- (2CGC) and 3'-neighbouring (GC2C) positions behaved very differently. Since the gel mobility shift analysis (Fig. 1) indicates that M.HhaI binds these duplex oligodeoxynucleotides only when AdoHcy is added, fluorescence titrations were performed in the presence of AdoHcy (Fig. 4A). However, addition of M.HhaI to the 2CGC or GC2C duplex oligodeoxynucleotides leads only to very small fluorescence increases (1.5- and 1.8-fold, respectively).

Fluorescence studies with M.TaqI

Titrations of duplex oligodeoxynucleotides containing 2-aminopurine with M.TaqI are shown in Figure 5, and the relative fluorescence changes are listed in Table 2. Addition of saturating amounts of M.TaqI to the duplex oligodeoxynucleotide TCG2, which carries the 2-aminopurine fluorophor at the target site of M.TaqI, results in a 13-fold increase of the fluorescence intensity. The titration data were fitted to the real solution of the quadratic binding equation for one binding site and resulted in a Kd of 120 ± 30 nM. This relatively weak binding is in conflict with the apparent tighter binding in the gel mobility shift assay (Fig. 2). Therefore, binding of M.TaqI to TCG2 was measured in a third independent assay. The intrinsic tryptophan fluorescence of M.TaqI increases upon binding of M.TaqI to specific DNA. Titration of M.TaqI with TCG2 at an excitation wavelength of 295 nm and an emission wavelength of 340 nm also results in a fluorescence increase (data not shown), which is highly dominated by the protein tryptophan fluorescence. This titration yielded a Kd of 120 ± 16 nM, which agrees very well with the Kd determined by 2-aminopurine fluorescence titration. Given the similarities of the Kd determined in the different fluorescence solution assays, we think that the gel mobility shift assay indicates too tight binding for M.TaqI. Fluorescence emission spectra of TCG2 at 10-fold higher concentrations (2.5 µM) in the absence and the presence of saturating amounts of M.TaqI are shown in Figure 6. The shape of the emission spectrum of TCG2 in the presence of M.TaqI (curve a) differs from the duplex spectrum (curve d), but resembles that of the free 2-aminopurine-2'-deoxynucleotide in Figure 3 (curve a). This is very similar to the result obtained for G2GC in the presence of M.HhaI. However, the emission spectrum of the M.TaqI-TCG2 complex has a maximum of 357 nm and is slightly blue-shifted compared with the emission maximum of the free 2-aminopurine-2'-deoxynucleotide at 360 nm.


Figure 5. Fluorescence titrations of TCG2 (l), TC2A ([diamonds]), TCGA2 ([circle]) at 250 nM concentration each with M.TaqI. Data fitting of the titration with TCG2 yielded a Kd of 120 ± 30 nM.

Titrations of the duplex oligodeoxynucleotides TC2A and TCGA2, in which the neighbouring bases of the target adenine are replaced by 2-aminopurine, lead only to 1.7- and 2.0-fold increases of the 2-aminopurine fluorescence intensity, respectively. Figure 6 also includes fluorescence spectra of TC2A (curve b) and TCGA2 (curve c) at 2.5 µM in the presence of saturating amounts of M.TaqI. In contrast with the M.TaqI-TCG2 complex, complexes between M.TaqI and duplexes carrying 2-aminopurine at the neighbouring positions (TC2A and TCGA2) show fluorescence emission spectra with a shape similar to those of the duplex oligodeoxynucleotides alone (data not shown).

DISCUSSION

We have used the C5-cytosine DNA methyltransferase M.HhaI as a paradigm for a DNA base flipping enzyme. It was demonstrated by X-ray crystallography of a series of ternary complexes between M.HhaI, various versions of substrate DNA and the product cofactor AdoHcy that the enzyme flips its target cytosine out of the DNA and into its active site (1,53-55). In addition, there is indirect evidence that base flipping does also occur in the binary M.HhaI-DNA complex. It was shown, that M.HhaI catalyses exchange of the proton at the 5-position of cytosine with solvent in the absence of cofactor (56). Base flipping in the binary complex is also supported by the observation that M.HhaI binds more tightly to duplex oligodeoxynucleotides containing thymine, uracil (20) and even adenine or guanine replacements for the target cytosine (21). This enhanced binding of M.HhaI to such duplexes is attributed to the lower energy required for opening a mismatched base pair upon formation of the binary complex. Recently, base flipping in the binary complex has been observed by 19F NMR spectroscopy (57). 2-Aminopurine also forms a mismatch with guanine in the G2GC duplex, and it is therefore not surprising that M.HhaI binds strongly to this duplex oligodeoxynucleotide in the gel shift assay.


Figure 6. Fluorescence emission spectra of duplex oligodeoxynucleotides (2.5 µM): curve (a) TCG2 in the presence of M.TaqI (7.5 µM), curve (b) TC2A in the presence of M.TaqI (7.5 µM), curve (c) TCGA2 in the presence of M.TaqI (7.5 µM) and curve (d) TCG2 alone.

Since base flipping results in a complete removal of the stacking interactions between the target base and its neighbours, and the fluorescence quenching of the 2-aminopurine base in dsDNA is mainly due to base stacking interactions, the 2-aminopurine fluorescence should increase dramatically if the 2-aminopurine base is flipped out of the DNA helix. Thus, the observed 54-fold increase of the 2-aminopurine fluorescence intensity upon addition of saturating amounts of M.HhaI to the duplex G2GC, in which the target cytosine is replaced by 2-aminopurine, is consistent with the 2-aminopurine base being flipped out of the double helix in the binary complex. The observation that the shape of the 2-aminopurine emission spectrum in the M.HhaI-G2GC complex is changed compared with the duplex spectrum but resembles that of the free 2-aminopurine-2'-deoxynucleotide, is also in agreement with an extrahelical 2-aminopurine in the binary complex. In addition, this may indicate that the flipped out 2-aminopurine base is solvent accessible to a quite large extent and that it is not locked in the catalytic pocket of the enzyme as was observed for the target base in the X-ray structures (1,53-55). It is indeed quite difficult to imagine how a much bulkier 2-aminopurine could replace cytosine in the active site pocket. Moreover, a lower electrophoretic mobility in the presence of AdoHcy of this complex compared with those containing cytosine at the target position (Fig. 1) indicates that this complex is less compact and suggests that the enzyme may not have undergone the complete conformational rearrangement of the active site loop required for catalysis (21). The absence of an effect of AdoHcy on the electrophoretic mobility of this complex could be related to our observation that the dissociation constants of G2GC in the presence and absence of AdoHcy are not significantly different (Fig. 5B). It should be pointed out that duplex oligonucleotides with cytosine at the target position do show an increased binding upon addition of AdoHcy in gel mobility shift experiments (21). The insensitivity of the Kd of G2GC to the addition of AdoHcy could be due to the sterically more demanding 2-aminopurine base at the target position, which does not allow an AdoHcy-induced conformational rearrangement of M.HhaI to increase binding.

In contrast with G2GC, the duplex oligodeoxynucleotides 2CGC and GC2C, in which the neighbouring bases of the target cytosine are replaced with 2-aminopurine, bound to M.HhaI only in the presence of AdoHcy in the gel shift assay and gave only small increases of the 2-aminopurine fluorescence emission upon titration with M.HhaI (1.5- and 1.8-fold, respectively). In these complexes base flipping of the target cytosine should lead to a 2-aminopurine which has lost its base stacking interactions to one of its neighbours. This situation can be compared with duplex oligodeoxynucleotides having 2-aminopurine at the 3'-end. Bloom et al. (32) showed that placing 2-aminopurine at the 3'-end of a duplex oligodeoxynucleotide results in a very low fluorescence intensity and thus only one stacking neighbour is sufficient to result in a large fluorescence quenching (25- to 125-fold depending on the nature of the 5'-neighbour of 2-aminopurine). Therefore, the small fluorescence increases in the M.HhaI-2CGC and M.HhaI-GC2C complexes are in accordance with the neighbouring cytosine being flipped out of the DNA helix.

M.HhaI does not bend its DNA substrate significantly (1,58) and the large 2-aminopurine fluorescence intensity of the M.HhaI-G2GC complex can solely be attributed to base flipping. Since the 2-aminopurine fluorescence in duplex oligodeoxynucleotides is highly quenched due to stacking interactions with neighbouring bases, DNA bending, kinking and base flipping induced by DNA binding proteins should have different effects on the 2-aminopurine fluorescence intensity. In general, smooth bending does not result in an unstacking of neighbouring base pairs and thus should not lead to a large increase of the 2-aminopurine fluorescence. In contrast, kinking of DNA, as observed in DNA complexes with the catabolite gene activator protein (CAP) (59), the TATA-box binding protein (TBP) (60,61) or the restriction endonuclease EcoRV (62), leads to unstacking of adjacent base pairs (63). This leads to a situation, in which each base at the kink has only one stacking neighbour and may be compared with the M.HhaI-2CGC and M.HhaI-GC2C complexes, in which 2-aminopurine has only one stacking neighbour due to base flipping, or to a duplex oligodeoxynucleotide, in which 2-aminopurine is placed at the end. Since the later arrangements do not lead to a large 2-aminopurine fluorescence increase, DNA kinking is also not expected to result in a large fluorescence increase. Only if both stacking neighbours are removed upon DNA binding, e.g. by base flipping, duplex oligodeoxynucleotides containing 2-aminopurine should show a large fluorescence increase. However, it should be noted, that a small 2-aminopurine fluorescence increase due to bending or kinking might also give a valuable fluorescence signal change, which can be used to study DNA binding.

Titrations of duplex oligodeoxynucleotides containing 2-amino-purine with the adenine-specific DNA methyltransferase M.TaqI lead to similar results as those with M.HhaI. Replacement of the target adenine with 2-aminopurine within the recognition sequence of M.TaqI (TCG2) yields a strongly enhanced 2-aminopurine fluorescence signal (13-fold) upon titration with M.TaqI. In addition, the shape of the 2-aminopurine fluorescence emission spectrum in the M.TaqI-TCG2 complex resembles that of the free 2-aminopurine-2'-deoxynucleotide. Addition of M.TaqI to duplex oligodeoxynucleotides bearing 2-aminopurine at the 5'-neighbouring position (TC2A) or at the 3'-neighbouring position (TCGA2) of the target adenine show only a 1.7- and 2.0-fold increase of the fluorescence intensity, respectively. In addition, the shapes of the fluorescence emission spectra are similar to those of the duplex oligodeoxynucleotides alone. The similarities of the results obtained with M.HhaI and M.TaqI strongly indicate a common base flipping mechanism for both DNA methyltransferases.

The lower fluorescence intensity of the M.TaqI-TCG2 complex compared with the M.HhaI-G2GC complex might be explained by different chemical environments of the 2-aminopurine base when flipped out of the DNA helix. It was suggested for M.TaqI, that the target adenine after being flipped out of the DNA will interact with NPPY (105-108), VVP (164-166) and F196 in the M.TaqI-DNA complex (17). Since the 2-aminopurine quantum yield is reduced in hydrophobic solvents (29) and the putative active site of M.TaqI is very hydrophobic, a reduced 2-aminopurine fluorescence intensity is expected. In addition, the 2-aminopurine fluorescence is blue-shifted in hydrophobic solvents (29) and the observed 3 nm blue shift of the 2-aminopurine emission maximum in the M.TaqI-TCG2 complex compared with the free 2-aminopurine-2'-deoxynucleotide supports this interpretation. Alternatively, the lower fluorescence intensity of the M.TaqI-TCG2 complex could be explained by different equilibria between an inner- and extrahelical state of the 2-aminopurine base in the M.TaqI-TCG2 and M.HhaI-G2GC complexes. 2-Aminopurine can form two Watson-Crick-like hydrogen bonds to the partner thymine in the TCG2 duplex, whereas in G2GC 2-aminopurine forms a mismatch with the partner guanine. Therefore, the equilibrium in the M.HhaI-G2GC complex could lie more on the extrahelical side compared with that in the M.TaqI-TCG2 complex, which could explain the higher 2-aminopurine fluorescence intensity of the M.HhaI-G2GC complex. A third explanation for the lower fluorescence of the M.TaqI-TCG2 complex could be that a certain fraction of the enzyme docks to the recognition sequence in the alternative orientation which does not lead to a flipped out 2-aminopurine base. However, this possibility can be excluded, because in studies with a duplex oligodeoxynucleotide, in which the target bases of both strands were replaced with 2-aminopurine, no higher fluorescence intensity is observed upon addition of M.TaqI compared with the M.TaqI-TCG2 complex (data not shown).

Recently, fluorescence studies with duplex oligodeoxynucleotides containing 2-aminopurine and the N6-adenine DNA methyltransferase M.EcoRI have been reported (43). Similar to our results with M.HhaI and M.TaqI, addition of stoichiometric amounts of M.EcoRI to a duplex oligodeoxynucleotide containing 2-aminopurine at the target site resulted in a large (14-fold) increase of the 2-aminopurine fluorescence. These findings with M.TaqI and M.EcoRI give experimental evidence that a base flipping mechanism similar to that described for the C5-cytosine DNA methyltransferases M.HhaI and M.HaeIII also operates in adenine-specific DNA methyltransferases. Since the active site residues of M.TaqI as well as other amino acids are highly conserved among N6-adenine DNA methyltransferases and N4-cytosine DNA methyltransferases (18,19,64), a common base flipping mechanism for all DNA methyltransferases seems likely (5). This hypothesis can now be tested experimentally by using duplex oligodeoxynucleotides, in which the target base is replaced by 2-aminopurine.

In conclusion, the C5-cytosine DNA methyltransferase M.HhaI, which is known to flip out its target base for catalysis, leads to a large increase of the 2-aminopurine fluorescence when added to duplex oligodeoxynucleotides containing 2-aminopurine at the target site. Addition of the N6-adenine DNA methyltransferase M.TaqI to duplex oligodeoxynucleotides, in which the target base is replaced by 2-aminopurine, also results in a strongly enhanced 2-aminopurine fluorescence emission. These results demonstrate that 2-aminopurine can be used as a fluorescence probe for DNA base flipping. In addition, this approach is suitable to determine Kd in the nanomolar range. Furthermore, it should be possible to use the 2-aminopurine fluorescence signal in stopped flow experiments to monitor DNA base flipping in real time.

ACKNOWLEDGEMENTS

We would like to thank Jack Benner and Cheryl Baxa from New England Biolabs for providing the M.TaqI expression vector and Nathalie Bleimling for the purification of M.TaqI. We also would like to thank Roger Goody for his continuous support and Bernard Connolly for carefully reading the manuscript. This work was supported by a grant from the Deutsche Forschungsgemeinschaft and from the Volkswagen-Stiftung.

REFERENCES

1 Klimasauskas,S., Kumar,S., Roberts,R.J. and Cheng,X. (1994) Cell, 76, 357-369. MEDLINE Abstract

2 Reinisch,K.M., Chen,L., Verdine,G.L. and Lipscomb,W.N. (1995) Cell, 82, 143-153. MEDLINE Abstract

3 Vassylyev,D.G., Kashiwagi,T., Mikami,Y., Ariyoshi,M., Iwai,S., Ohtsuka,E. and Morikawa,K. (1995) Cell, 83, 773-782. MEDLINE Abstract

4 Slupphaug,G., Mol,C.D., Kavli,B., Arvai,A.S., Krokan,H.E. and Tainer,J.A. (1996) Nature, 384, 87-92. MEDLINE Abstract

5 Roberts,R.J. (1995) Cell, 82, 9-12. MEDLINE Abstract

6 Moore,M.H., Gulbis,J.M., Dodson,E.J., Demple,B. and Moody,P.C.E. (1994) EMBO J., 13, 1495-1501. MEDLINE Abstract

7 Vrielink,A., Rüger,W., Driessen,H.P.C. and Freemont,P.S. (1994) EMBO J., 13, 3413-3422. MEDLINE Abstract

8 Mol,C.D., Kuo,C.-F., Thayer,M.M., Cunningham,R.P. and Tainer,J.A. (1995) Nature, 374, 381-386. MEDLINE Abstract

9 Park,H.-W., Kim,S.-T., Sancar,A. and Deisenhofer,J. (1995) Science, 268, 1866-1872. MEDLINE Abstract

10 Thayer,M.M., Ahern,H., Xing,D., Cunningham,R.P. and Tainer,J.A. (1995) EMBO J., 14, 4108-4120. MEDLINE Abstract

11 Yamagata,Y., Kato,M., Odawara,K., Tokuno,Y., Nakashima,Y., Matsushima,N., Yasumura,K., Tomita,K., Ihara,K., Fujii,Y., Nakabeppu,Y., Sekiguchi,M. and Fujii,S. (1996) Cell, 86, 311-319. MEDLINE Abstract

12 Labahn,J., Schärer,O.D., Long,A., Ezaz-Nikpay,K., Verdine,G.L. and Ellenberger,T.E. (1996) Cell, 86, 321-329. MEDLINE Abstract

13 Gong,W., O'Gara,M., Blumenthal,R.M. and Cheng,X. (1997) Nucleic Acids Res., 25, 2702-2715. MEDLINE Abstract

14 McClelland,M. (1981) Nucleic Acids Res., 9, 6795-6804. MEDLINE Abstract

15 Labahn,J., Granzin,J., Schluckebier,G., Robinson,D.P., Jack,W.E., Schildkraut,I. and Saenger,W. (1994) Proc. Natl. Acad. Sci. USA, 91, 10957-10961. MEDLINE Abstract

16 Schluckebier,G., Labahn,J., Granzin,J., Schildkraut,I. and Saenger,W. (1995) Gene, 157, 131-134. MEDLINE Abstract

17 Schluckebier,G., O'Gara,M., Saenger,W. and Cheng,X. (1995) J. Mol. Biol., 247, 16-20. MEDLINE Abstract

18 Klimasauskas,S., Timinskas,A., Menkevicius,S., Butkienè,D., Butkus,V. and Janulaitis,A. (1989) Nucleic Acids Res., 17, 9823-9832. MEDLINE Abstract

19 Malone,T., Blumenthal,R.M. and Cheng,X. (1995) J. Mol. Biol., 253, 618-632. MEDLINE Abstract

20 Yang,A.S., Shen,J.-C., Zingg,J.-M., Mi,S. and Jones,P.A. (1995) Nucleic Acids Res., 23, 1380-1387. MEDLINE Abstract

21 Klimasauskas,S. and Roberts,R.J. (1995) Nucleic Acids Res., 23, 1388-1395. MEDLINE Abstract

22 Cal,S. and Connolly,B.A. (1997) J. Biol. Chem., 272, 490-496. MEDLINE Abstract

23 Millar,D.P. (1996) Curr. Opin. Struct. Biol., 6, 322-326. MEDLINE Abstract

24 McLaughlin,L.W., Leong,T., Benseler,F. and Piel,N. (1988) Nucleic Acids Res., 16, 5631-5644. MEDLINE Abstract

25 Connolly,B.A. (1991) In Eckstein,F. (ed.) Oligonucleotides and Analogues: A Practical Approach. IRL Press, Oxford, pp. 155-183.

26 Connolly,B.A. (1992) Methods Enzymol., 211, 36-53. MEDLINE Abstract

27 Schmidt,S. and Cech,D. (1995) Nucleosides Nucleotides, 14, 1445-1452.

28 Fujimoto,J., Nuesca,Z., Mazurek,M. and Sowers,L.C. (1996) Nucleic Acids Res., 24, 754-759. MEDLINE Abstract

29 Ward,D.C., Reich,E. and Stryer,L. (1969) J. Biol. Chem., 244, 1228-1237. MEDLINE Abstract

30 Guest,C.R., Hochstrasser,R.A., Sowers,L.C. and Millar,D.P. (1991) Biochemistry, 30, 3271-3279. MEDLINE Abstract

31 Xu,D., Evans,K.O. and Nordlund,T.M. (1994) Biochemistry, 33, 9592-9599. MEDLINE Abstract

32 Bloom,L.B., Otto,M.R., Beechem,J.M. and Goodman,M.F. (1993) Biochemistry, 32, 11247-11258. MEDLINE Abstract

33 Hochstrasser,R.A., Carver,T.E., Sowers,L.C. and Millar,D.P. (1994), Biochemistry, 33, 11971-11979. MEDLINE Abstract

34 Bloom,L.B., Otto,M.R., Eritja,R., Reha-Krantz,L.J., Goodman,M.F. and Beechem,J.M. (1994) Biochemistry, 33, 7576-7586. MEDLINE Abstract

35 West Frey,M., Sowers,L.C., Millar,D.P. and Benkovic,S.J. (1995) Biochemistry, 34, 9185-9192.

36 Marquez,L.A. and Reha-Krantz,L.J. (1996) J. Biol. Chem., 271, 28903-28911. MEDLINE Abstract

37 Újvári,A. and Martin,C.T. (1996) Biochemistry, 35, 14574-14582. MEDLINE Abstract

38 Jia,Y., Kumar,A. and Patel,S.S. (1996) J. Biol. Chem., 271, 30451-30458. MEDLINE Abstract

39 Sastry,S.S. and Ross,B.M. (1996) Biochemistry, 35, 15715-15725. MEDLINE Abstract

40 Dunkak,K.S., Otto,M.R. and Beechem,J.M. (1996) Anal. Biochem., 243, 234-244. MEDLINE Abstract

41 Raney,K.D., Sowers,L.C., Millar,D.P. and Benkovic,S.J. (1994) Proc. Natl. Acad. Sci. USA, 91, 6644-6648. MEDLINE Abstract

42 Bjornson,K.P., Moore,K.J.M. and Lohman,T.M. (1996) Biochemistry, 35, 2268-2282. MEDLINE Abstract

43 Allan,B.W. and Reich,N.O. (1996) Biochemistry, 35, 14757-14762. MEDLINE Abstract

44 Roberts,R.J., Myers,P.A., Morrison,A. and Murray,K. (1976) J. Mol. Biol., 103, 199-208. MEDLINE Abstract

45 Mann,M.B. and Smith,H.O. (1979) In Usdin,E., Borchardt,R.T. and Creveling,C.R. (eds), Proceedings of the Conference on Transmethylation. Elsevier, New York, pp. 483-492.

46 Andrus,A. (1992) Evaluating and Isolation Synthetic Oligonucleotides. Applied Biosystems.

47 Kumar,S., Cheng,X., Pflugrath,J.W. and Roberts,R.J. (1992) Biochemistry, 31, 8648-8653. MEDLINE Abstract

48 Laemmli,U.K. (1970) Nature, 227, 680-685. MEDLINE Abstract

49 Schluckebier,G., Kozak,M., Bleimling,N., Weinhold,E. and Saenger,W. (1997) J. Mol. Biol., 265, 56-67. MEDLINE Abstract

50 Bradford,M.M. (1976) Anal. Biochem., 72, 248-254. MEDLINE Abstract

51 Reinstein,J., Vetter,I.R., Schlichting,I., Rösch,P., Wittinghofer,A. and Goody,R.S. (1990) Biochemistry, 29, 7440-7450. MEDLINE Abstract

52 Leatherbarrow,R.J. (1992) GraFit Version 3.0, Erithacus Software Ltd., Staines, UK.

53 O'Gara,M., Roberts,R.J. and Cheng,X. (1996) J. Mol. Biol., 263, 597-606. MEDLINE Abstract

54 O'Gara,M., Klimasauskas,S., Roberts,R.J. and Cheng,X. (1996) J. Mol. Biol., 261, 634-645. MEDLINE Abstract

55 Kumar,S., Horton,J.R., Jones,G.D., Walker,R.T., Roberts,R.J. and Cheng,X. (1997) Nucleic Acids Res., 25, 2773-2783. MEDLINE Abstract

56 Wu,J.C. and Santi,D.V. (1987) J. Biol. Chem., 262, 4778-4786. MEDLINE Abstract

57 Klimasauskas,S., Szyperski,T., Serva,S., Wüthrich,K. (1998) EMBO J., 17 317-324.

58 García,R.A., Bustamante,C.J. and Reich,N.O. (1996) Proc. Natl. Acad. Sci. USA, 93, 7618-7622. MEDLINE Abstract

59 Schultz,S.C., Shields,G.C. and Steitz,T.A. (1991) Science, 253, 1001-1007. MEDLINE Abstract

60 Kim,Y., Geiger,J.H., Hahn,S. and Sigler,P.B. (1993) Nature, 365, 512-520. MEDLINE Abstract

61 Kim,J.L., Nikolov,D.B. and Burley,S.K. (1993) Nature, 365, 520-527. MEDLINE Abstract

62 Winkler,F.K., Banner,D.W., Oefner,C., Tsernoglou,D., Brown,R.S., Heathman,S.P., Bryan,R.K., Martin,P.D., Petratos,K. and Wilson,K.S. (1993) EMBO J., 12, 1781-1795. MEDLINE Abstract

63 Travers,A.A. (1991) Curr. Opin. Struct. Biol., 1, 114-122.

64 Timinskas,A., Butkus,V. and Janulaitis,A. (1995) Gene, 157, 3-11. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +49 231 1206 357; Fax: +49 231 1206 229; Email: elmar.weinhold@mpi-dortmund.mpg.de


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk
Last modification: 6 Feb 1998
Copyright© Oxford University Press, 1998.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
R. K. Neely, G. Tamulaitis, K. Chen, M. Kubala, V. Siksnys, and A. C. Jones
Time-resolved fluorescence studies of nucleotide flipping by restriction enzymes
Nucleic Acids Res., November 1, 2009; 37(20): 6859 - 6870.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. Sandin, G. Stengel, T. Ljungdahl, K. Borjesson, B. Macao, and L. M. Wilhelmsson
Highly efficient incorporation of the fluorescent nucleotide analogs tC and tCO by Klenow fragment
Nucleic Acids Res., July 1, 2009; 37(12): 3924 - 3933.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Kim, S. Reddy, D. Y. Kim, A. Rich, S. Lee, K. K. Kim, and Y.-G. Kim
Base extrusion is found at helical junctions between right- and left-handed forms of DNA and RNA
Nucleic Acids Res., July 1, 2009; 37(13): 4353 - 4359.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
B. Liang, E. J. Kahen, K. Calvin, J. Zhou, M. Blanco, and H. Li
Long-distance placement of substrate RNA by H/ACA proteins
RNA, October 1, 2008; 14(10): 2086 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Bahr, V. Gabelica, A. Granzhan, M.-P. Teulade-Fichou, and E. Weinhold
Selective recognition of pyrimidine-pyrimidine DNA mismatches by distance-constrained macrocyclic bis-intercalators
Nucleic Acids Res., September 1, 2008; 36(15): 5000 - 5012.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. A. Carpenter and A. S. Bhagwat
DNA base flipping by both members of the PspGI restriction-modification system
Nucleic Acids Res., September 1, 2008; 36(16): 5417 - 5425.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Daujotyte, Z. Liutkeviciute, G. Tamulaitis, and S. Klimasauskas
Chemical mapping of cytosines enzymatically flipped out of the DNA helix
Nucleic Acids Res., June 1, 2008; 36(10): e57 - e57.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Yuan, X. W. Lou, E. Rhoades, H. Chen, and L. A. Archer
T4 DNA ligase is more than an effective trap of cyclized dsDNA
Nucleic Acids Res., August 13, 2007; 35(16): 5294 - 5302.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Kimoto, T. Mitsui, Y. Harada, A. Sato, S. Yokoyama, and I. Hirao
Fluorescent probing for RNA molecules by an unnatural base-pair system
Nucleic Acids Res., August 13, 2007; 35(16): 5360 - 5369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Liebert, J. R. Horton, S. Chahar, M. Orwick, X. Cheng, and A. Jeltsch
Two Alternative Conformations of S-Adenosyl-L-homocysteine Bound to Escherichia coli DNA Adenine Methyltransferase and the Implication of Conformational Changes in Regulating the Catalytic Cycle
J. Biol. Chem., August 3, 2007; 282(31): 22848 - 22855.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Tamulaitis, M. Zaremba, R. H. Szczepanowski, M. Bochtler, and V. Siksnys
Nucleotide flipping by restriction enzymes analyzed by 2-aminopurine steady-state fluorescence
Nucleic Acids Res., July 9, 2007; 35(14): 4792 - 4799.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
S. A. Harris
Modelling the biomechanical properties of DNA using computer simulation
Phil Trans R Soc A, December 15, 2006; 364(1849): 3319 - 3334.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Estabrook and N. Reich
Observing an Induced-fit Mechanism during Sequence-specific DNA Methylation
J. Biol. Chem., December 1, 2006; 281(48): 37205 - 37214.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. R. Horton, X. Zhang, R. Maunus, Z. Yang, G. G. Wilson, R. J. Roberts, and X. Cheng
DNA nicking by HinP1I endonuclease: bending, base flipping and minor groove expansion
Nucleic Acids Res., February 9, 2006; 34(3): 939 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Malta, G. F. Moolenaar, and N. Goosen
Base Flipping in Nucleotide Excision Repair
J. Biol. Chem., January 27, 2006; 281(4): 2184 - 2194.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. K. Neely, D. Daujotyte, S. Grazulis, S. W. Magennis, D. T. F. Dryden, S. Klimasauskas, and A. C. Jones
Time-resolved fluorescence of 2-aminopurine as a probe of base flipping in M.HhaI-DNA complexes
Nucleic Acids Res., December 9, 2005; 33(22): 6953 - 6960.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T.-J. Su, M. R. Tock, S. U. Egelhaaf, W. C. K. Poon, and D. T. F. Dryden
DNA bending by M.EcoKI methyltransferase is coupled to nucleotide flipping
Nucleic Acids Res., June 7, 2005; 33(10): 3235 - 3244.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. B. Gaied, N. Glasser, N. Ramalanjaona, H. Beltz, P. Wolff, R. Marquet, A. Burger, and Y. Mély
8-vinyl-deoxyadenosine, an alternative fluorescent nucleoside analog to 2'-deoxyribosyl-2-aminopurine with improved properties
Nucleic Acids Res., February 17, 2005; 33(3): 1031 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. Merkiene and S. Klimasauskas
Probing a rate-limiting step by mutational perturbation of AdoMet binding in the HhaI methyltransferase
Nucleic Acids Res., January 13, 2005; 33(1): 307 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Estabrook, R. Lipson, B. Hopkins, and N. Reich
The Coupling of Tight DNA Binding and Base Flipping: IDENTIFICATION OF A CONSERVED STRUCTURAL MOTIF IN BASE FLIPPING ENZYMES
J. Biol. Chem., July 23, 2004; 279(30): 31419 - 31428.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T.-J. Su, B. A. Connolly, C. Darlington, R. Mallin, and D. T. F. Dryden
Unusual 2-aminopurine fluorescence from a complex of DNA and the EcoKI methyltransferase
Nucleic Acids Res., April 23, 2004; 32(7): 2223 - 2230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. G. Malygin, W. M. Lindstrom Jr., V. V. Zinoviev, A. A. Evdokimov, S. L. Schlagman, N. O. Reich, and S. Hattman
Bacteriophage T4Dam (DNA-(Adenine-N6)-methyltransferase): EVIDENCE FOR TWO DISTINCT STAGES OF METHYLATION UNDER SINGLE TURNOVER CONDITIONS
J. Biol. Chem., October 24, 2003; 278(43): 41749 - 41755.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. M. Kallman, M. Sahlin, and M. Ohman
ADAR2 A->I editing: site selectivity and editing efficiency are separate events
Nucleic Acids Res., August 15, 2003; 31(16): 4874 - 4881.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
D. Daujotyte, G. Vilkaitis, L. Manelyte, J. Skalicky, T. Szyperski, and S. Klimasauskas
Solubility engineering of the HhaI methyltransferase
Protein Eng. Des. Sel., April 1, 2003; 16(4): 295 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. Christine, A. W. MacFarlane IV, K. Yang, and R. J. Stanley
Cyclobutylpyrimidine Dimer Base Flipping by DNA Photolyase
J. Biol. Chem., October 4, 2002; 277(41): 38339 - 38344.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. E. R. Newby, E. Y. Lau, and T. C. Bruice
A theoretical examination of the factors controlling the catalytic efficiency of the DNA-(adenine-N6)-methyltransferase from Thermus aquaticus
PNAS, June 11, 2002; 99(12): 7922 - 7927.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
X. Cheng and R. J. Roberts
AdoMet-dependent methylation, DNA methyltransferases and base flipping
Nucleic Acids Res., September 15, 2001; 29(18): 3784 - 3795.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. G. Malygin, A. A. Evdokimov, V. V. Zinoviev, L. G. Ovechkina, W. M. Lindstrom, N. O. Reich, S. L. Schlagman, and S. Hattman
A dual role for substrate S-adenosyl-L-methionine in the methylation reaction with bacteriophage T4 Dam DNA-[N6-adenine]-methyltransferase
Nucleic Acids Res., June 1, 2001; 29(11): 2361 - 2369.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Rist and J. Marino
Association of an RNA kissing complex analyzed using 2-aminopurine fluorescence
Nucleic Acids Res., June 1, 2001; 29(11): 2401 - 2408.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. S. Szegedi, N. O. Reich, and R. I. Gumport
Substrate binding in vitro and kinetics of RsrI [N6-adenine] DNA methyltransferase
Nucleic Acids Res., October 15, 2000; 28(20): 3962 - 3971.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
I. Pompizi, A. Haberli, and C. J. Leumann
Oligodeoxynucleotides containing conformationally constrained abasic sites: a UV and fluorescence spectroscopic investigation on duplex stability and structure
Nucleic Acids Res., July 15, 2000; 28(14): 2702 - 2708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. M. Lindstrom Jr., J. Flynn, and N. O. Reich
Reconciling Structure and Function in HhaI DNA Cytosine-C-5 Methyltransferase
J. Biol. Chem., February 18, 2000; 275(7): 4912 - 4919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Jeltsch, F. Christ, M. Fatemi, and M. Roth
On the Substrate Specificity of DNA Methyltransferases. ADENINE-N6 DNA METHYLTRANSFERASES ALSO MODIFY CYTOSINE RESIDUES AT POSITION N4
J. Biol. Chem., July 9, 1999; 274(28): 19538 - 19544.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Holz, N. Dank, J. E. Eickhoff, G. Lipps, G. Krauss, and E. Weinhold
Identification of the Binding Site for the Extrahelical Target Base in N6-Adenine DNA Methyltransferases by Photo-cross-linking with Duplex Oligodeoxyribonucleotides Containing 5-Iodouracil at the Target Position
J. Biol. Chem., May 21, 1999; 274(21): 15066 - 15072.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Vilkaitis, A. Dong, E. Weinhold, X. Cheng, and S. Klimasauskas
Functional Roles of the Conserved Threonine 250 in the Target Recognition Domain of HhaI DNA Methyltransferase
J. Biol. Chem., December 1, 2000; 275(49): 38722 - 38730.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Vilkaitis, E. Merkiene, S. Serva, E. Weinhold, and S. Klimasauskas
The Mechanism of DNA Cytosine-5 Methylation. KINETIC AND MUTATIONAL DISSECTION OF HhaI METHYLTRANSFERASE
J. Biol. Chem., June 8, 2001; 276(24): 20924 - 20934.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Y. Yi-Brunozzi, O. M. Stephens, and P. A. Beal
Conformational Changes That Occur during an RNA-editing Adenosine Deamination Reaction
J. Biol. Chem., October 5, 2001; 276(41): 37827 - 37833.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. A. Evdokimov, V. V. Zinoviev, E. G. Malygin, S. L. Schlagman, and S. Hattman
Bacteriophage T4 Dam DNA-[N6-adenine]Methyltransferase. KINETIC EVIDENCE FOR A CATALYTICALLY ESSENTIAL CONFORMATIONAL CHANGE IN THE TERNARY COMPLEX
J. Biol. Chem., January 4, 2002; 277(1): 279 - 286.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (143K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (108)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Holz, B.
Right arrow Articles by Weinhold, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holz, B.
Right arrow Articles by Weinhold, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?